Savagen Tablets

Savagen Tablets – Breakthrough Therapy for Heart Failure

Savagen is a specialized cardiovascular medication used for the long-term management of chronic heart conditions. It belongs to a modern class of drugs that combines an Angiotensin II receptor antagonist with a neprilysin inhibitor, containing the generic blend of Valsartan and Sacubitril. Savagen is specifically indicated for the treatment of heart failure (NYHA class II-IV) in adult patients with documented systolic dysfunction. The medication works by simultaneously inhibiting the breakdown of beneficial peptides while blocking harmful cardiovascular signals. This unique dual action helps the heart muscle function more efficiently, reduces blood pressure, and promotes the excretion of excess sodium. Clinically, Savagen has been shown to significantly reduce the risk of cardiovascular death and hospitalization in heart failure patients. It represents a major advancement in preventing the progression of heart disease and improving the patient's overall quality of life. The multiple available strengths allow for precise dose titration based on the patient's individual clinical response.

• Treats chronic heart failure (NYHA class II-IV).
• Indicated for patients with systolic dysfunction.
• Combines ARB and neprilysin inhibitor for superior protection.
• Available as: Tablets 50mg, 100mg, and 200mg.